125 filings
8-K
DYAI
Dyadic International Inc., DE
14 May 24
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
4:47pm
8-K
DYAI
Dyadic International Inc., DE
28 Mar 24
Dyadic Reports 2023 Full Year Results and Recent Company Progress
4:07pm
8-K
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
DYAI
Dyadic International Inc., DE
8 Nov 23
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
4:09pm
8-K
DYAI
Dyadic International Inc., DE
6 Oct 23
Other Events
4:20pm
8-K
w703 lik6
6 Oct 23
Termination of a Material Definitive Agreement
4:10pm
8-K
azg73ph5b
19 Sep 23
Dyadic Announces Development and License Agreement to Commercialize Animal-Free Alternative Proteins Using DapibusTM
8:30am
8-K
d3s7th4in240raa7u9
9 Aug 23
Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
4:08pm
8-K/A
s9vr6 ixaei6wqhkqnpa
15 Jun 23
Submission of Matters to a Vote of Security Holders
6:04am
8-K
aqth4mrixc7thfgh1tq1
12 Jun 23
Submission of Matters to a Vote of Security Holders
6:26pm
8-K
t5l pvn931z
10 May 23
Dyadic Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
4:35pm
8-K
26sscs80 8ffc0gqvzk
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
8-K
2c36ik
10 Apr 23
Changes in Registrant's Certifying Accountant
5:00pm
8-K
h2ne90a
29 Mar 23
Dyadic Reports 2022 Year End Results and Recent Company Progress
4:32pm
8-K
0604u a40be2n
29 Mar 23
Amendments to Articles of Incorporation or Bylaws
8:30am
8-K
utbqpqyb2ukpbu
7 Mar 23
Dyadic Provides Phase 1 Clinical Trial Update for its DYAI-100 COVID-19 Recombinant Protein
8:35am
8-K
pow qqn4a3
22 Feb 23
Changes in Registrant's Certifying Accountant
5:00pm
8-K
8qi 3weeq1561q
24 Jan 23
Other Events
8:45am
8-K
xtbkc9u2vum g5
23 Jan 23
Dyadic Announces Sale of Equity Interest in Alphazyme
5:22pm
8-K
j50fs6z
4 Jan 23
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
8:35am